Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Adehossi

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Trials|December 13, 2022
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisationMahamadou Bassirou Souleymane, Tom Decroo, Alphazazi Soumana, et al.
Tropical Medicine and Infectious Disease|August 25, 2022
Prevalence of Mutations in the <i>Pfdhfr</i>, <i>Pfdhps,</i> and <i>Pfmdr1</i> Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, NigerIbrahima Issa, Mahaman Moustapha Lamine, Veronique Hubert, et al.
The New England Journal of Medicine|March 23, 2017
Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in NigerSheila Isanaka, Ousmane Guindo, Celine Langendorf, et al.
BMC Infectious Diseases|May 28, 2026
Extension of seasonal malaria chemoprevention to older children: a pragmatic comparative study in two health districts in the Zinder region, NigerMédard Djedanem, Alkassoum Ibrahim, Mahaman Y Nazibou, et al.
Medecine Tropicale Et Sante Internationale|March 12, 2025
[Acute flaccid paralysis surveillance in Niger from 1998 to 2021]Maman Bachir Goni Dit Alassan, Zeidou Maiga Abdoulaye, Ibrahim Alkassoum Salifou, et al.
International Health|April 14, 2022
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort studyMahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, et al.
Plos Medicine|July 2, 2021
Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trialSheila Isanaka, Céline Langendorf, Monica Malone McNeal, et al.
Access Microbiology|December 17, 2024
Inducible clindamycin resistance among clinical Gram-positive cocci in a tertiary hospital in Niger RepublicAbdourahamane Yacouba, Malika Zeidou Alassoum, Boubacar Marou Soumana, et al.
African Journal of Laboratory Medicine|January 4, 2021
Laboratory organisation and management of SARS-CoV-2 infection in Niger, West AfricaAbdourahamane Yacouba, Adamou Lagaré, Daouada Alhousseini Maiga, et al.
Conflict and Health|December 15, 2021
Clinical features and predictors of mortality among hospitalized patients with COVID-19 in NigerPatrick D M C Katoto, Issoufou Aboubacar, Batouré Oumarou, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Trials|December 13, 2022
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisationMahamadou Bassirou Souleymane, Tom Decroo, Alphazazi Soumana, et al.
Tropical Medicine and Infectious Disease|August 25, 2022
Prevalence of Mutations in the <i>Pfdhfr</i>, <i>Pfdhps,</i> and <i>Pfmdr1</i> Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, NigerIbrahima Issa, Mahaman Moustapha Lamine, Veronique Hubert, et al.
The New England Journal of Medicine|March 23, 2017
Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in NigerSheila Isanaka, Ousmane Guindo, Celine Langendorf, et al.
BMC Infectious Diseases|May 28, 2026
Extension of seasonal malaria chemoprevention to older children: a pragmatic comparative study in two health districts in the Zinder region, NigerMédard Djedanem, Alkassoum Ibrahim, Mahaman Y Nazibou, et al.
Medecine Tropicale Et Sante Internationale|March 12, 2025
[Acute flaccid paralysis surveillance in Niger from 1998 to 2021]Maman Bachir Goni Dit Alassan, Zeidou Maiga Abdoulaye, Ibrahim Alkassoum Salifou, et al.
International Health|April 14, 2022
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort studyMahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, et al.
Plos Medicine|July 2, 2021
Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trialSheila Isanaka, Céline Langendorf, Monica Malone McNeal, et al.
Access Microbiology|December 17, 2024
Inducible clindamycin resistance among clinical Gram-positive cocci in a tertiary hospital in Niger RepublicAbdourahamane Yacouba, Malika Zeidou Alassoum, Boubacar Marou Soumana, et al.
African Journal of Laboratory Medicine|January 4, 2021
Laboratory organisation and management of SARS-CoV-2 infection in Niger, West AfricaAbdourahamane Yacouba, Adamou Lagaré, Daouada Alhousseini Maiga, et al.
Conflict and Health|December 15, 2021
Clinical features and predictors of mortality among hospitalized patients with COVID-19 in NigerPatrick D M C Katoto, Issoufou Aboubacar, Batouré Oumarou, et al.
Pageof 5